These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8715981)

  • 1. [Profitability is influencing decisions. We must not calculate costs only but also the results].
    Vail S
    Krankenpfl Soins Infirm; 1996 Apr; 89(4):66-8. PubMed ID: 8715981
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost versus quality. Making ethical decisions in home care today.
    Springstead K
    Caring; 1996 Oct; 15(10):38-40, 44, 46. PubMed ID: 10161682
    [No Abstract]   [Full Text] [Related]  

  • 3. Health-based profitability.
    Ronning PL
    Hosp Technol Ser; 1995 Jul; 14(7):4-6. PubMed ID: 10144659
    [No Abstract]   [Full Text] [Related]  

  • 4. Health policy implications of the RAND medical outcomes study: improving the value of depression treatment.
    Sturm R; Wells KB
    Behav Healthc Tomorrow; 1996 Oct; 5(5):63-6. PubMed ID: 10161578
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative costs and effectiveness of specialist and general internist ambulatory care for patients with 2 chronic musculoskeletal conditions.
    Anderson JJ; Ruwe M; Miller DR; Kazis L; Felson DT; Prashker M
    J Rheumatol; 2002 Jul; 29(7):1488-95. PubMed ID: 12136910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-inclusive evaluation: a banquet of approaches for including costs, benefits, and cost-effectiveness and cost-benefit analyses in your next evaluation.
    Yates BT
    Eval Program Plann; 2009 Feb; 32(1):52-4. PubMed ID: 18977532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary decisions and health economics.
    Glazer WM
    J Clin Psychiatry; 1998; 59 Suppl 19():23-9. PubMed ID: 9847049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care value: cost ratio.
    Goodin RR
    J Ky Med Assoc; 1995 Jan; 93(1):7-8. PubMed ID: 7852828
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
    Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.
    Schoenbaum M; Sherbourne C; Wells K
    J Affect Disord; 2005 Aug; 87(2-3):319-25. PubMed ID: 16005520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease management program for the elderly with heart failure.
    Belardinelli R
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):318-9. PubMed ID: 17443095
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases.
    Durand-Zaleski I; Earlam S; Fordy C; Davies M; Allen-Mersh TG
    Cancer; 1998 Sep; 83(5):882-8. PubMed ID: 9731890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health services will be judged on both quality and cost.
    Hardcastle M
    Nurs Times; 2009 Sep 15-21; 105(36):13. PubMed ID: 19835192
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of improving primary care treatment of late-life depression.
    Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
    Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost offset effect strategies for the provision of mental health care services.
    Kocakülâh MC; Valadares KJ
    J Health Care Finance; 2003; 30(1):31-40. PubMed ID: 12967242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare cost crisis and quality gap: our national dilemma.
    Darling H
    Healthc Financ Manage; 2005 May; 59(5):64-8. PubMed ID: 15938351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
    Opmeer BC; Heydendael VM; De Borgie CA; Spuls PI; Bossuyt PM; Bos JD; De Rie MA
    Arch Dermatol; 2004 Jun; 140(6):685-90. PubMed ID: 15210458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of treating mental illness from a managed care perspective.
    Docherty JP
    J Clin Psychiatry; 1999; 60 Suppl 3():49-52; discussion 53. PubMed ID: 10073378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.